Philip Hampton

2.1k total citations
51 papers, 567 citations indexed

About

Philip Hampton is a scholar working on Dermatology, Economics and Econometrics and Immunology. According to data from OpenAlex, Philip Hampton has authored 51 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 15 papers in Economics and Econometrics and 12 papers in Immunology. Recurrent topics in Philip Hampton's work include Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (10 papers) and Autoimmune Bullous Skin Diseases (7 papers). Philip Hampton is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (10 papers) and Autoimmune Bullous Skin Diseases (7 papers). Philip Hampton collaborates with scholars based in United Kingdom, New Zealand and United States. Philip Hampton's co-authors include Nick J. Reynolds, C.E.M. Griffiths, Catherine Smith, Mark Lunt, Zenas Z N Yiu, Richard B. Warren, K.J. Mason, P.M. Farr, J. J. Lloyd and Brian Diffey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of Cellular Physiology.

In The Last Decade

Philip Hampton

44 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Hampton United Kingdom 14 245 227 90 86 82 51 567
Viviana Lora Italy 17 304 1.2× 242 1.1× 106 1.2× 69 0.8× 113 1.4× 42 725
J.M. Mommers Netherlands 13 216 0.9× 366 1.6× 61 0.7× 38 0.4× 25 0.3× 26 505
L.L.A. Lecluse Netherlands 9 266 1.1× 491 2.2× 120 1.3× 75 0.9× 35 0.4× 10 600
Mark BY Tang Singapore 13 211 0.9× 81 0.4× 100 1.1× 62 0.7× 97 1.2× 21 422
Alessandra Narcisi Italy 19 448 1.8× 459 2.0× 145 1.6× 155 1.8× 91 1.1× 105 886
Yichuan Xia United States 4 338 1.4× 637 2.8× 156 1.7× 108 1.3× 34 0.4× 6 892
Laura Calabrese Italy 14 229 0.9× 131 0.6× 70 0.8× 65 0.8× 72 0.9× 51 436
Kasper Fjellhaugen Hjuler Denmark 14 206 0.8× 386 1.7× 175 1.9× 58 0.7× 41 0.5× 20 548
Avani Joshi United States 13 192 0.8× 397 1.7× 314 3.5× 43 0.5× 43 0.5× 35 939
Vimal H. Prajapati Canada 13 588 2.4× 249 1.1× 179 2.0× 89 1.0× 72 0.9× 87 861

Countries citing papers authored by Philip Hampton

Since Specialization
Citations

This map shows the geographic impact of Philip Hampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Hampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Hampton more than expected).

Fields of papers citing papers by Philip Hampton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Hampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Hampton. The network helps show where Philip Hampton may publish in the future.

Co-authorship network of co-authors of Philip Hampton

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Hampton. A scholar is included among the top collaborators of Philip Hampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Hampton. Philip Hampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yiu, Zenas Z N, Oras Alabas, C.E.M. Griffiths, et al.. (2025). Drug survival of IL‐23 and IL‐17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study. Journal of the European Academy of Dermatology and Venereology. 39(10). 1785–1795. 1 indexed citations
2.
Wittmann, Miriam, Isabelle L Smith, Sarah Brown, et al.. (2024). Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT. Health Technology Assessment. 28(59). 1–123.
3.
Kokolakis, Georgios, Mark Lebwohl, Peter Foley, et al.. (2024). AB0490 BIMEKIZUMAB EFFICACY THROUGH 3 YEARS IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: LONG-TERM POOLED ANALYSIS FROM BE BRIGHT. Annals of the Rheumatic Diseases. 83. 1513–1513.
5.
Dissemond, Joachim, Angelo Valerio Marzano, Philip Hampton, & Alex G. Ortega‐Loayza. (2023). Pyoderma Gangrenosum: Treatment Options. Drugs. 83(14). 1255–1267. 28 indexed citations
7.
Hampton, Philip, J. Berth‐Jones, C.E. Duarte Williamson, et al.. (2021). British Association of Dermatologists guidelines for the management of people with rosacea 2021*. British Journal of Dermatology. 185(4). 725–735. 29 indexed citations
8.
Carrozzo, M, et al.. (2020). A retrospective cohort study reporting rituximab treatment for 33 patients with immunobullous disease. Journal of Oral Pathology and Medicine. 50(1). 92–97. 2 indexed citations
10.
Gopee, Nusayhah Hudaa, et al.. (2020). Toxic epidermal necrolysis occurring with immune checkpoint inhibitors. Dermatology Online Journal. 26(8). 13 indexed citations
11.
Yiu, Zenas Z N, K.J. Mason, Juliet N. Barker, et al.. (2019). A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis. British Journal of Dermatology. 181(6). 1265–1271. 16 indexed citations
12.
13.
Staines, Konrad & Philip Hampton. (2012). Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 114(1). e49–e56. 10 indexed citations
14.
Hampton, Philip, et al.. (2011). Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2). Journal of Cellular Physiology. 227(4). 1529–1537. 20 indexed citations
15.
Hampton, Philip, et al.. (2011). Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid. Journal of Dermatological Case Reports. 5(4). 74–6. 25 indexed citations
16.
Hampton, Philip, Brian Angus, & A.J. Carmichael. (2005). A case of Schopf-Schulz-Passarge syndrome. Clinical and Experimental Dermatology. 30(5). 528–530. 20 indexed citations
17.
Hampton, Philip, P.M. Farr, Brian Diffey, & J. J. Lloyd. (2004). Implication for photosensitive patients of ultraviolet A exposure in vehicles. British Journal of Dermatology. 151(4). 873–876. 27 indexed citations
18.
Hampton, Philip, Niamh Leonard, & Clifford M. Lawrence. (2003). Case 5. Clinical and Experimental Dermatology. 28(5). 573–574. 1 indexed citations
19.
Hampton, Philip, L. Harrison, & Denis Pereira Gray. (1993). Demand for hospital services following admission with suspected myocardial infarction in 1983 and 1989.. PubMed. 25(3). 91–4. 7 indexed citations
20.
Hampton, Philip. (1969). Empirical Evidence on the Determinants of Interregional Trade Flows. Economic Development and Cultural Change. 18(1, Part 1). 34–39.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026